Centers for Disease Control awards contract to Kephera Diagnostics for point-of-care test for Taeniasis

Framingham, MA – November 13, 2018.  Kephera Diagnostics has won a $150,000 Phase I SBIR contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a point-of-care test for Taeniasis, the company announced today.  The Phase I contract will support the generation of key immunological reagents with which the test will be…

National Institutes of Health awards grant to Kephera Diagnostics for new point-of-care test for Chagas disease

Framingham, MA – September 18, 2018.  The National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH), has awarded a two-year, $599,316 SBIR grant to Kephera Diagnostics to develop a new test for Chagas disease, the company announced today.  Under the SBIR grant program, this Phase I grant is…

Resources

Zika Virus WHO Resource for Zika Virus Disease CDC Resource for Zika Virus Disease Current Zika Transmission Worldwide Pan American Health Organization About Zika Virus ELSEVIER Zika Virus Resource Center NEJM – Zika Virus Articles and Other Resources Chagas Disease WHO Resource for Chagas Disease CDC Resource for Chagas Disease Pan American Health Organization About…